-transparent.png){kind=logo}
Oxidative polymorphism of debrisoquine (DBQ) was assessed in 84 patients (81 male) with histologically proven bronchogenic carcinoma and in 143 healthy male smokers. 80 (95%) patients and 133 (93%) controls, with a metabolic ratio (MR) below 12.6, were classified as extensive metabolisers of DBQ (no significant difference between patients and controls). Only 1 of the 73 patients with epidermoid or microcytic carcinomas was classified as a poor metaboliser (PM) (P = 0.031 compared with controls). 63 patients (75%) and 110 controls (77%) showed a very fast oxidative rate, with MR values under 1 (not significant). The EM phenotype of DBQ might be a secondary genetic risk factor for developing bronchogenic carcinoma in male smokers.
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
January 1986,
Progress in clinical and biological research,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
January 1988,
Cancer chemotherapy and pharmacology,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
January 1990,
British journal of clinical pharmacology,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
October 1990,
British journal of clinical pharmacology,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
February 1982,
Clinical pharmacology and therapeutics,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
January 1992,
European journal of clinical pharmacology,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
February 1990,
British journal of clinical pharmacology,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
October 1977,
Lancet (London, England),
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
January 1989,
Psychopharmacology series,
J Benítez, and
J M Ladero, and
C Jara, and
J A Carrillo, and
J Cobaleda, and
A Llerena, and
E Vargas, and
J J Muñoz
September 1977,
Lancet (London, England),
